Correlation Between Walker Dunlop and Ocuphire Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Ocuphire Pharma, you can compare the effects of market volatilities on Walker Dunlop and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Ocuphire Pharma.

Diversification Opportunities for Walker Dunlop and Ocuphire Pharma

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Walker and Ocuphire is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Ocuphire Pharma go up and down completely randomly.

Pair Corralation between Walker Dunlop and Ocuphire Pharma

Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 0.23 times more return on investment than Ocuphire Pharma. However, Walker Dunlop is 4.35 times less risky than Ocuphire Pharma. It trades about -0.16 of its potential returns per unit of risk. Ocuphire Pharma is currently generating about -0.58 per unit of risk. If you would invest  11,429  in Walker Dunlop on August 25, 2024 and sell it today you would lose (580.00) from holding Walker Dunlop or give up 5.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy13.64%
ValuesDaily Returns

Walker Dunlop  vs.  Ocuphire Pharma

 Performance 
       Timeline  
Walker Dunlop 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Walker Dunlop are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Walker Dunlop is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Ocuphire Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ocuphire Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest inconsistent performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Walker Dunlop and Ocuphire Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Walker Dunlop and Ocuphire Pharma

The main advantage of trading using opposite Walker Dunlop and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.
The idea behind Walker Dunlop and Ocuphire Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences